282 related articles for article (PubMed ID: 313868)
1. Immunologic aspects of malignant tumors.
Ariyan S
Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
[No Abstract] [Full Text] [Related]
2. Clinical assessment of T and B lymphocyte functions.
Farnes P
R I Med J (1976); 1976 Feb; 59(2):51-6, 71. PubMed ID: 1082619
[No Abstract] [Full Text] [Related]
3. [Regulator antibodies and suppressive cells: interactions in the helper reaction].
Voisin GA
Ann Immunol (Paris); 1977; 128(1-2):431-43. PubMed ID: 300607
[No Abstract] [Full Text] [Related]
4. Defence systems of the body, immunosuppression and immunotherapy.
James DG
J R Nav Med Serv; 1976; 62(2):60-72. PubMed ID: 787517
[No Abstract] [Full Text] [Related]
5. Developmental aspects of delayed hypersensitivity.
Berkel AI
Boll Ist Sieroter Milan; 1974; 53(1):suppl:147-51. PubMed ID: 4277433
[No Abstract] [Full Text] [Related]
6. The suppressor-cell network in cancer (second of two parts).
Broder S; Waldmann TA
N Engl J Med; 1978 Dec; 299(24):1335-41. PubMed ID: 362202
[No Abstract] [Full Text] [Related]
7. Old age and immunity.
Binette JP
Prim Care; 1982 Mar; 9(1):7-13. PubMed ID: 6978498
[TBL] [Abstract][Full Text] [Related]
8. Suppression of human B- and T-lymphocyte response in vitro with serum from rabbits immunized with antibody-coated autologous or allogeneic cells.
Weimer R; Terness P; Opelz G
Transplant Proc; 1987 Oct; 19(5):4289-93. PubMed ID: 3499693
[No Abstract] [Full Text] [Related]
9. [Clinical aspects of immunological phenomena in human neoplasms].
Hancock BW
Recenti Prog Med; 1978 Sep; 65(3):205-16. PubMed ID: 360326
[No Abstract] [Full Text] [Related]
10. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
Haba S; Kitagawa M
Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
[No Abstract] [Full Text] [Related]
11. The gordian knot of tumour immunology.
Amlot P
Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
[No Abstract] [Full Text] [Related]
12. [Immunology of tumors: correlation between immunological competence, clinical evolution and therapeutic response].
Kopersztych S; Naspitz CK; Mendes NF
Rev Hosp Clin Fac Med Sao Paulo; 1975; 30(6):513-6. PubMed ID: 1108153
[No Abstract] [Full Text] [Related]
13. [Lymphocytes. Roles in cellular immunity and humoral immunity].
Golovtchenko AM; Raichvarg D
Ann Biol Clin (Paris); 1975; 33(2):63-74. PubMed ID: 1080972
[TBL] [Abstract][Full Text] [Related]
14. [Current concepts of the growth mechanisms of the immune response].
Voĭtenok NN
Ter Arkh; 1980; 52(9):132-40. PubMed ID: 6449091
[No Abstract] [Full Text] [Related]
15. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy.
Ablin RJ
Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313
[No Abstract] [Full Text] [Related]
16. Immunotherapy: concepts and nursing implications.
McCalla JL
Nurs Clin North Am; 1976 Mar; 11(1):59-71. PubMed ID: 1083016
[TBL] [Abstract][Full Text] [Related]
17. [Immunity and hypersensitivity in Hodgkin's lymphoma].
Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
[No Abstract] [Full Text] [Related]
18. The role of cellular and humoral factors in infections.
Neu HC
Clin Haematol; 1976 Jun; 5(2):449-65. PubMed ID: 780033
[No Abstract] [Full Text] [Related]
19. Cell-mediated immunity: relevance to ocular diseases.
Meyers RL
Invest Ophthalmol; 1975 Sep; 14(9):635-9. PubMed ID: 1080483
[No Abstract] [Full Text] [Related]
20. [Controlled study of unspecific cellular immunity in cancer patients].
Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
